INS and type 1 diabetes mellitus: The UK National Institute for Health and Care Excellence (NICE) and the Pharmaceutical Management Agency (PHARMAC) in New Zealand have recommended human insulins as first line therapy, but insulin analogues can be prescribed under specific circumstances, as an option for those patients with type 1 diabetes whose lifestyle is significantly restricted by recurrent symptomatic hypoglycemic episodes [29,30].